SYSTEMATIC REVIEW
Published on 23 Sep 2022
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials

doi 10.3389/fimmu.2022.999704
- 6,344 views
- 22 citations
7,168
Total downloads
20k
Total views and downloads
SYSTEMATIC REVIEW
Published on 23 Sep 2022
SYSTEMATIC REVIEW
Published on 24 May 2022
ORIGINAL RESEARCH
Published on 28 Mar 2022